| P50 | author | James Dziura | Q85558986 |
| | E Jennifer Edelman | Q86191217 |
| P2093 | author name string | David A Fiellin | |
| | William C Becker | |
| | Denise Esserman | |
| | Philip A Chan | |
| | Elizabeth Porter | |
| | Deborah H Cornman | |
| | Gabriel Rebick | |
| | Jessica Yager | |
| | Kenneth Morford | |
| | Srinivas B Muvvala | |
| P2860 | cites work | Evidence-based practices for substance use disorders | Q24614016 |
| | Interventions for tobacco use cessation in people living with HIV and AIDS | Q26471480 |
| | Stepped wedge randomised controlled trials: systematic review of studies published between 2010 and 2014 | Q26798053 |
| | A comparison of methods to test mediation and other intervening variable effects | Q29010534 |
| | Three approaches to qualitative content analysis | Q29619566 |
| | Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions | Q30244921 |
| | The stepped wedge trial design: a systematic review. | Q30478284 |
| | Organizational readiness to change assessment (ORCA): development of an instrument based on the Promoting Action on Research in Health Services (PARIHS) framework | Q30489082 |
| | A critical synthesis of literature on the promoting action on research implementation in health services (PARIHS) framework | Q30497408 |
| | Monitoring and managing metabolic effects of antipsychotics: a cluster randomized trial of an intervention combining evidence-based quality improvement and external facilitation | Q30558767 |
| | Impact of defined clinical population and missing data on temporal trends in HIV viral load estimation within a health care system | Q30894245 |
| | The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients | Q33644060 |
| | Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries | Q33711008 |
| | Systematic review of stepped wedge cluster randomized trials shows that design is particularly used to evaluate interventions during routine implementation | Q33848710 |
| | The relationship between baseline Organizational Readiness to Change Assessment subscale scores and implementation of hepatitis prevention services in substance use disorders treatment clinics: a case study | Q33986417 |
| | The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment | Q34050760 |
| | Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America | Q34823231 |
| | A Guide for applying a revised version of the PARIHS framework for implementation | Q35248465 |
| | Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone | Q35566908 |
| | Systematic review and meta-analysis of practice facilitation within primary care settings | Q35684163 |
| | HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study | Q35686969 |
| | Patient and provider priorities for self-reported domains of HIV clinical care | Q36277120 |
| | Unhealthy alcohol and illicit drug use are associated with decreased quality of HIV care | Q36287158 |
| | Measuring retention in HIV care: the elusive gold standard | Q36428000 |
| | Design and analysis of stepped wedge cluster randomized trials | Q36531160 |
| | Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. | Q36689488 |
| | HIV primary care providers--Screening, knowledge, attitudes and behaviors related to alcohol interventions | Q36826868 |
| | The role of formative evaluation in implementation research and the QUERI experience | Q36917206 |
| | Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact | Q37063730 |
| | Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone | Q37393366 |
| | Qualitative and mixed methods provide unique contributions to outcomes research | Q37415879 |
| | Disparities in receipt of 5As for smoking cessation in diverse primary care and HIV clinics | Q37678221 |
| | Reengagement in Care After a Gap in HIV Care Among a Population of Privately Insured Persons with HIV in the United States. | Q39010074 |
| | Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States | Q39293352 |
| | Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs | Q40431814 |
| | Engagement and Substance Dependence in a Primary Care-Based Addiction Treatment Program for People Infected with HIV and People at High-Risk for HIV Infection | Q40616512 |
| | Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings | Q43667828 |
| | Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative | Q44141522 |
| | Effects of a multifaceted implementation intervention to increase utilization of pharmacological treatments for alcohol use disorders in the US Veterans Health Administration. | Q45326019 |
| | Stepped wedge designs could reduce the required sample size in cluster randomized trials | Q47246023 |
| | Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial | Q47554209 |
| | A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians | Q50330676 |
| | Mixed methods formative evaluation of a collaborative care program to decrease risky opioid prescribing and increase non-pharmacologic approaches to pain management. | Q51735109 |
| | Impact of Practice Facilitation in Primary Care on Chronic Disease Care Processes and Outcomes: a Systematic Review | Q57173989 |
| | Testing implementation facilitation of a primary care-based collaborative care clinical program using a hybrid type III interrupted time series design: a study protocol | Q59800727 |
| | Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities | Q60044816 |
| | Comparison of rapid vs in-depth qualitative analytic methods from a process evaluation of academic detailing in the Veterans Health Administration | Q61804077 |
| | Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH) | Q64063833 |
| | AHRQ updates on primary care research: the AHRQ Patient-Centered Medical Home Resource Center | Q85937842 |
| | Changes in alcohol use associated with changes in HIV disease severity over time: A national longitudinal study in the Veterans Aging Cohort | Q88957971 |
| | "No more falling through the cracks": A qualitative study to inform measurement of integration of care of HIV and opioid use disorder | Q90708283 |
| | Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial | Q90730513 |
| | Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals | Q91070909 |
| | Time and Organizational Cost for Facilitating Implementation of Primary Care Mental Health Integration | Q91624770 |
| | Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV | Q92129127 |
| | Preferences for implementation of HIV pre-exposure prophylaxis (PrEP): Results from a survey of primary care providers | Q92343676 |
| | Predictors of timely opioid agonist treatment initiation among veterans with and without HIV | Q92413244 |
| | Integration of care for HIV and opioid use disorder | Q92436591 |
| | Receipt and predictors of smoking cessation pharmacotherapy among veterans with and without HIV | Q92975087 |
| | Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine | Q94550818 |
| | Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities | Q97649395 |
| | Practice facilitation to implement alcohol-related care in Veterans Health Administration liver clinics: a study protocol | Q98657492 |
| P304 | page(s) | 106156 | |
| P577 | publication date | 2020-09-22 | |
| P1433 | published in | Contemporary Clinical Trials | Q5164971 |
| P1476 | title | Working with HIV clinics to adopt addiction treatment using implementation facilitation (WHAT-IF?): Rationale and design for a hybrid type 3 effectiveness-implementation study | |